...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Journal of Urology >Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.
【24h】

Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

机译：前列腺癌患者中补充疗法的流行和使用模式：流行病学分析。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE: We determine the prevalence and patterns of the use of complementary therapies among patients with and those at high risk for prostate cancer. MATERIALS AND METHODS: A cross-sectional survey was performed of men presenting to 2 urban tertiary urology clinics for prostate cancer evaluation or followup, and those attending a prostate cancer support group. All men diagnosed with and those at high risk (positive family history or abnormal prostate specific antigen) for prostate cancer were eligible for study. A 9-item self-administered, anonymous questionnaire about complementary therapies was administered. RESULTS: Of 357 patients who received the survey 155 from the urology clinics and 113 from the support group responded, for a total response rate of 75%. Of the patients presenting to urology clinics and the support group 27.4 and 38.9% with and 25.8 and 80% at high risk for prostate cancer, respectively, used some form of complementary therapy. The use significantly differed according to disease status (p = 0.001), and was highest among men who were clinically disease-free after radical therapy. Of the patients 24% did not inform the urologist of using alternative therapy. CONCLUSIONS: The prevalence of the use of complementary therapy among patients with or at increased risk for prostate cancer was high and dependent on the disease state. Urologists should be aware of this pattern of use, and consider the potential effects when assessing patients for and with prostate cancer.
机译：目的：我们确定前列腺癌患者和高风险患者中使用补充疗法的普遍性和模式。材料与方法：对参加2个城市三级泌尿外科诊所进行前列腺癌评估或随访的男性和参加前列腺癌支持小组的男性进行了横断面调查。所有诊断出患有前列腺癌的男性和那些处于高风险（阳性家族史或前列腺特异性抗原异常）的男性都有资格进行研究。进行了9项关于补充疗法的自我管理的匿名问卷调查。结果：在357名接受泌尿科诊所调查的患者中，有113名来自支持组的患者得到了答复，总答复率为75％。在泌尿科门诊和支持组就诊的患者中，分别有27.4％和38.9％的前列腺癌高危患者以及25.8％和80％的前列腺癌高危患者采用了某种形式的辅助治疗。使用方法根据疾病状况而有显着差异（p = 0.001），在根治性治疗后无临床疾病的男性中使用率最高。在患者中，有24％并未告知泌尿科医生是否使用替代疗法。结论：在患有前列腺癌或处于前列腺癌风险较高的患者中，使用补充疗法的患病率很高，并且取决于疾病状态。泌尿科医师应意识到这种使用方式，并在评估患者是否患有前列腺癌时考虑其潜在的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号